Abstract
Gadolinium(III) complexes, such as Gd-DTPA (Magnevist®) and Gd-DOTA (Dotarem®), are widely used as magnetic resonance imaging (MRI) contrast agents (CAs) in clinical practice. Both high relaxivity and stability are crucial requirements for Gd(III)-based materials to be used as MRI-CAs. The relaxivity is generally improved by increasing the hydration number (q) and/or embedding Gd(III) complexes in/onto slow rotating objects, while the coordination stability can be enhanced when nitrogen donors are replaced with oxygen donors according to the hard-soft-acid-base (HSAB) principle. In this work, we synthesized a tripodal hexadentate all-oxygen-donor ligand bearing three pairs of carboxylate and amine-N-oxide chelating groups and used microemulsion technique to further form nanosized coordination networks. The obtained Gd(III)-containing nanoparticles exhibited a narrow size distribution centered at 90 nm according to dynamic laser scattering and transmission electron microscopy analysis. The relaxivity of the nanoparticles reached 25.95 s−1 per mM of Gd(III), about six times higher than that of the commercial MRI-CAs. The competing coordination experiments showed that Gd(III) ions were firmly bonded in the coordination networks, complying well with the safety requirement for clinical applications. Moreover, the nanoparticles had low cytotoxicity and displayed good biocompatibility for potential in vivo applications.
Similar content being viewed by others
References
Wallyn J, Anton N, Akram S, Vandamme TF (2019) Biomedical imaging: principles, technologies, clinical aspects, contrast agents, limitations and future trends in nanomedicines pharm. Res 36:78. https://doi.org/10.1007/s11095-019-2608-5
Akakuru OU, Iqbal MZ, Saeed M et al (2019) The transition from metal-based to metal-free contrast agents for T1 magnetic resonance imaging enhancement. Bioconjugate Chem 30:2264–2286. https://doi.org/10.1021/acs.bioconjchem.9b00499
Bottrill M, Kwok L, Long N (2006) Lanthanoids in magnetic resonance imaging. Chem Soc Rev 35:557–571. https://doi.org/10.1039/b516376p
Datta A, Raymond KN (2009) Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents. Acc Chem Res 42:938–947
Raymond KN, Pierre VC (2005) Next generation, high relaxivity gadolinium MRI agents. Bioconjugate Chem 16:3–8. https://doi.org/10.1021/bc049817y
Wahsner J, Gale EM, Rodriguez-Rodriguez A, Caravan P (2019) Chemistry of MRI contrast agents: current challenges and new frontiers. Chem Rev 119:957–1057. https://doi.org/10.1021/acs.chemrev.8b00363
Villaraza AJL, Bumb A, Brechbiel MW (2010) Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem Rev 110:2921–2959. https://doi.org/10.1021/Cr900232t
Zhang B, Cheng L, Duan B et al (2019) Gadolinium complexes of diethylenetriamine-N-oxide pentaacetic acid-bisamide: a new class of highly stable MRI contrast agents with a hydration number of 3. Dalton Trans 48:1693–1699. https://doi.org/10.1039/C8DT04478C
Hermann P, Kotek J, Kubicek V, Lukes I (2008) Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes. Dalton Trans. https://doi.org/10.1039/b719704g
Aime S, Calabi L, Cavallotti C et al (2004) [Gd-AAZTA]-: a new structural entry for an improved generation of MRI contrast agents. Inorg Chem 43:7588–7590. https://doi.org/10.1021/ic0489692
Caravan P, Ellison JJ, McMurry TJ, Lauffer RB (1999) Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 99:2293–2352. https://doi.org/10.1021/cr980440x
Chan K, Wong W-T (2007) Small molecular gadolinium(III) complexes as MRI contrast agents for diagnostic imaging. Coord Chem Rev 251:2428–2451. https://doi.org/10.1016/j.ccr.2007.04.018
Caravan P (2006) Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 35:512–523
Chen Y, Zhu Q, Cui X et al (2014) Preparation of highly efficient MRI contrast agents through complexation of cationic GdIII-containing metallosurfactant with biocompatible polyelectrolytes. Chem Eur J 20:12477–12482. https://doi.org/10.1002/chem.201402530
Martinelli J, Thangavel K, Tei L, Botta M (2014) Dendrimeric beta-cyclodextrin/Gd(III) chelate supramolecular host-guest adducts as high-relaxivity MRI probes. Chem Eur J 20:10944–10952. https://doi.org/10.1002/chem.201402418
Xiong R, Cheng L, Tian Y et al (2016) Hyperbranched polyethylenimine based polyamine-N-oxide-carboxylate chelates of gadolinium for high relaxivity MRI contrast agents. RSC Adv 6:28063–28068
Menjoge AR, Kannan RM, Tomalia DA (2010) Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 15:171–185
Fedorenko S, Bespalova S, Mustafina A et al (2016) Tuning the non-covalent confinement of Gd(III) complexes in silica nanoparticles for high T1-weighted MR imaging capability. Colloids Surf B. https://doi.org/10.1016/j.colsurfb.2016.10.025
W Lin, W Rieter, K Taylor-Pashow (2009) Modular synthesis of functional nanoscale coordination polymers. Angewandte Chemie (International ed. in English) 48: 650–658. https://doi.org/10.1002/anie.200803387
Catala L, Volatron F, Brinzei D, Mallah T (2009) Functional coordination nanoparticles. Inorg Chem 48:3360–3370. https://doi.org/10.1021/ic8012574
Spokoyny AM, Kim D, Sumrein A, Mirkin CA (2009) Infinite coordination polymer nano- and microparticle structures. Chem Soc Rev 38:1218–1227. https://doi.org/10.1039/b807085g
Rocca J, Liu D, Lin W (2011) Nanoscale metal-organic frameworks for biomedical imaging and drug delivery. Acc Chem Res 44:957–968. https://doi.org/10.1021/ar200028a
He C, Liu D, Lin W (2015) Nanomedicine applications of hybrid nanomaterials built from metal-ligand coordination bonds: nanoscale metal-organic frameworks and nanoscale coordination. Polymers Chem Rev 115:11079–11108. https://doi.org/10.1021/acs.chemrev.5b00125
Rowe M, Chang C-C, Thamm D et al (2009) Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers. Langmuir 25:9487–9499. https://doi.org/10.1021/la900730b
Rowe M, Thamm D, Kraft S, Boyes S (2009) Polymer-modified gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer. Biomacromol 10:983–993. https://doi.org/10.1021/bm900043e
Rieter WJ, Taylor KML, An HY, Lin WL, Lin WB (2006) Nanoscale metal-organic frameworks as potential multimodal contrast enhancing agents. J Am Chem Soc 128:9024–9025. https://doi.org/10.1021/Ja0627444
Dong X, Ding YX, Wu P, Wang CC, Schafer CG (2017) Preparation of MRI-visible gadolinium methacrylate nanoparticles with low cytotoxicity and high magnetic relaxivity. J Mater Sci 52:7625–7636. https://doi.org/10.1007/s10853-017-1070-1
Barker-Griffith A, Goldberg J, Abraham J (2011) Ocular pathologic features and gadolinium deposition in nephrogenic systemic fibrosis. Arch Ophthalmol 129:661–663. https://doi.org/10.1001/archophthalmol.2011.89
Cowper S, Kuo P, Bucala R (2007) Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders. Arthritis Rheum 56:3173–3175. https://doi.org/10.1002/art.22926
Cowper S (2008) Gadolinium—is it to blame? J Cutan Pathol 35:520–522. https://doi.org/10.1111/j.1600-0560.2008.01027.x
Wollanka H, Weidenmaier W, Giersig C (2009) NSF after Gadovist exposure: a case report and hypothesis of NSF development. Nephrol Dial Transplant 24:3882–3884. https://doi.org/10.1093/ndt/gfp494
Ayers PW, Parr RG, Pearson RG (2006) Elucidating the hard/soft acid/base principle: a perspective based on half-reactions. J Chem Phys 124:194107. https://doi.org/10.1063/1.2196882
Pearson RG (1963) Hard and soft acids and bases. J Am Chem Soc 85:3533–3539. https://doi.org/10.1021/ja00905a001
Liu X, Lin L, Feng X (2011) Chiral N,N′-Dioxides: new ligands and organocatalysts for catalytic asymmetric reactions. Acc Chem Res 44:574–587. https://doi.org/10.1021/ar200015s
Gao B, Wen Y, Yang Z, Huang X, Liu X, Feng X (2008) Asymmetric ring opening of meso-epoxides with aromatic amines catalyzed by a new proline-based N,N′-dioxide-indium Tris(triflate) complex. Adv Synth Catal 350:385–390. https://doi.org/10.1002/adsc.200700474
Liu X, Lin L, Feng X (2009) Amide-based bifunctional organocatalysts in asymmetric reactions. Chem Commun. https://doi.org/10.1039/B913411E
Shang D, Liu Y, Zhou X, Liu X, Feng X (2009) A N, N′-dioxide–copper(II) complex as an efficient catalyst for the enantioselective and diastereoselective mannich-type reaction of Glycine Schiff bases with aldimines. Chem Eur J 15:3678–3681. https://doi.org/10.1002/chem.200900118
Martins AF, Eliseeva SV, Carvalho HF et al (2014) A bis(pyridine N-oxide) analogue of DOTA: relaxometric properties of the Gd(III) complex and efficient sensitization of visible and NIR-emitting lanthanide(III) cations including Pr(III) and Ho(III). Chem Eur J 20:14834–14845. https://doi.org/10.1002/chem.201403856
Zadmard R, Schrader T, Grawe T, Kraft A (2002) Self-assembly of molecular capsules in polar solvents. Org Lett 4:1687–1690. https://doi.org/10.1021/ol0257631
Mastalerz M, Lauer J, Zhang W-S, Rominger F, Schröder R (2017) Shape-persistent [4+4] imine cages with a truncated tetrahedral geometry. Chem Eur J. https://doi.org/10.1002/chem.201705713
Bellin M-F, van der Molen A (2008) Extracellular gadolinium-based contrast media: an overview. Eur J Radiol 66:160–167. https://doi.org/10.1016/j.ejrad.2008.01.023
Laurent S, Elst LV, Muller RN (2006) Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging 1:128–137
Nimesh S, Kumar R, Chandra R (2006) Novel polyallylamine–dextran sulfate–DNA nanoplexes: highly efficient non-viral vector for gene delivery. Int J Pharm 320:143–149. https://doi.org/10.1016/j.ijpharm.2006.03.050
Goodman CM, McCusker CD, Yilmaz T, Rotello VM (2004) Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjugate Chem 15:897–900. https://doi.org/10.1021/bc049951i
Choimet M, Hyoung-Mi K, Jae-Min O, Tourrette A, Drouet C (2016) Nanomedicine: interaction of biomimetic apatite colloidal nanoparticles with human blood components. Colloids Surf B 145:87–94. https://doi.org/10.1016/j.colsurfb.2016.04.038
Han Y, Wang X, Dai H, Li S (2012) Nanosize and surface charge effects of hydroxyapatite nanoparticles on red blood cell suspensions. ACS Appl Mater Interfaces 4:4616–4622. https://doi.org/10.1021/am300992x
Boas U, Heegaard PMH (2004) Dendrimers in drug research. Chem Soc Rev 33:43–63. https://doi.org/10.1039/B309043B
Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Fröhlich E (2009) The role of nanoparticle size in hemocompatibility. Toxicology 258:139–147. https://doi.org/10.1016/j.tox.2009.01.015
Loretz B, Bernkop-Schnürch A (2007) vitro cytotoxicity testing of non-thiolated and thiolated chitosan nanoparticles for oral gene delivery. Nanotoxicology 1:139–148. https://doi.org/10.1080/17435390701554200
Wang Q, Shen M, Zhao T et al (2015) Low toxicity and long circulation time of polyampholyte-coated magnetic nanoparticles for blood pool contrast agents. Sci Rep 5:7774. https://doi.org/10.1038/srep07774
Zhu Q, Yang H, Li YY et al (2016) HP-DO3A-based amphiphilic MRI contrast agents and relaxation enhancement through their assembly with polyelectrolytes. J Mater Chem B 4:7241–7248
Zhu Q, Yuan ZY, Qian WQ et al (2017) Spherical polyelectrolyte brushes as a novel platform for paramagnetic relaxation enhancement and passive Tumor Targeting. Adv Healthcare Mater 6:201700071. https://doi.org/10.1002/Adhm.201700071
McKinlay AC, Morris RE, Horcajada P et al (2010) BioMOFs: metal-organic frameworks for biological and medical applications. Angew Chem Int Ed Engl 49:6260–6266. https://doi.org/10.1002/anie.201000048
Park KM, Kim H, Murray J, Koo J, Kim K (2017) A facile preparation method for nanosized MOFs as a multifunctional material for cellular imaging and drug delivery. Supramol Chem 29:441–445. https://doi.org/10.1080/10610278.2016.1266359
Verwilst P, Eliseeva SV, Vander Elst L et al (2012) A tripodal ruthenium-gadolinium metallostar as a potential α(v)β(3) integrin specific bimodal imaging contrast agent. Inorg Chem 51:6405–6411. https://doi.org/10.1021/ic300717m
Liu D, He C, Poon C, Lin W (2014) Theranostic nanoscale coordination polymers for magnetic resonance imaging and bisphosphonate delivery. J Mater Chem B 2:8249–8255. https://doi.org/10.1039/C4TB00751D
Park J, Baek M, Choi E et al (2009) Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T 1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T 1 MR images. ACS Nano 3:3663–3669. https://doi.org/10.1021/nn900761s
Bridot J-L, Faure A-C, Laurent S et al (2007) Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc 129:5076–5084. https://doi.org/10.1021/ja068356j
Acknowledgements
The authors gratefully acknowledge the financial support from National Natural Science Foundation of China (21274042, 21503078), the Fundamental Research Funds for the Central Universities (22221818014), and Shanghai Leading Academic Discipline Project (B502). AH thanks the “Eastern Scholar Professorship” support from Shanghai local government.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
There are no conflicts to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Xu, N., Xu, K., Tang, W. et al. Formation of nanosized Gd(III) coordination networks with tripodal amine-N-oxide type ligand through microemulsions to achieve high relaxivity and exceptional stability for MRI applications. J Mater Sci 55, 13206–13215 (2020). https://doi.org/10.1007/s10853-020-04946-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10853-020-04946-3